Global
Our Story

Share the latest information

Our Story
News
2024-05-11
International Conference 及2024 BIO International Convention
Shanghai, China, May 11, 2024 - Shanghai Novamab Biopharmaceuticals Co., Ltd., a biotechnology company dedicated to the research and development of innovative nanobody drugs, announced that Dr. Yakun
More
2021-11-29
New drug progress I Rocky announced that its LQ036 (recombinant anti-IL-4Ra single-domain antibody aerosol) was accepted by IND!
On November 26, 2021, Shanghai Luoqi Bio-pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Luoqi Biotechnology") announced that its application for LQ036 (recombinant anti-IL-4Ra single-domain antibody aerosol) IND, which is independently developed and has independent intellectual property rights, was accepted by the National Drug Administration Drug Evaluation Center (CDE) (acceptance number: CXSL2101446). In addition, LQ036 drug is undergoing clinical phase I study in Australia. From the results of the current subjects, LQ036 has good safety.
More
2021-11-29
Rocky Business School I met a different person and achieved a better Rocky
On November 26, 2021, the business school of Shanghai Luoqi Bio-pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Luoqi Business School") officially opened! The first training course was held in the conference room of Phase 3 of the International Medical Park. The theme of this training was "Meet a different person and make a better Luoqi". The training invited Dr. Wan Yakun, general manager of Luoqi Biology, to deliver a speech.
More
2021-10-18
Tongxin · Co-creation I The fourth anniversary celebration of Loqi Biology was successfully held!
At 15:00 on October 15, the celebration of the fourth anniversary of Luoqi Biology kicked off in the 10th building of the third phase of Shanghai Zhoupu Medical Park. Dr. Wan Yakun, the general manager of the company, attended the celebration. Dr. Wan Yakun delivered a speech at the Siqing event: "Looking back on the four years of hard work, the development of Loqi Biology cannot be separated from the efforts and efforts of every colleague. Fortunately, we are from Loqi, and we also hope to meet better Loqi with you!"
More
2021-10-11
New drug progress I Loki Biological announced that its anti-IL-4R nanoantibody LQ036 clinical phase I study completed the first subject administration!
Recently, Shanghai Luoqi Bio-pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Luoqi Biotech") announced that its independently developed anti-IL-4R nanoantibody (LQ036 aerosol) drug, which has independent intellectual property rights, has completed the first clinical study on asthma patients in Australia for the first time!
More
2021-06-29
Good news I Rocky Biology has been recognized as a pilot patent enterprise in Shanghai!
Recently, according to the requirements of the Measures for the Identification and Administration of Pilot and Demonstration Units of Patent Work in Shanghai Enterprises and Institutions (H.ZB [2017] No. 62), Shanghai Luoqi Bio-pharmaceutical Technology Co., Ltd. was recognized as the "pilot enterprise of patent work in Shanghai in 2021" through expert review and other procedures, and after the study and decision of the Municipal Intellectual Property Office and the Municipal Market Supervision Bureau.
More
2021-04-08
Good news I Luoqi Biological has obtained tens of millions of A+rounds of financing!
Following the announcement of the completion of the A round financing of 100 million yuan a few days ago, recently, Loqi Biotech announced the completion of the A+round financing of tens of millions of yuan again. This round of financing was led by the Hongyun Fund, a partnership between Huatai Zijin and Alibaba Health. Daoyuan Capital co-invested, and Haoyue Capital continued to serve as the exclusive financial adviser.
More
2021-03-12
Good news I Luoqi Biological has completed a round of financing of billion yuan!
Recently, Luoqi Biological announced to complete the A-round financing of billion yuan. This round of financing is led by Tianhui Capital, co-invested by Taiyu Investment and Fuhui Venture Capital, and Haoyue Capital serves as the exclusive financial adviser of this round of financing.
More
2021-03-08
Good news I Rocky Biology has obtained the high-tech enterprise certificate!
Recently, Shanghai Luoqi Bio-pharmaceutical Technology Co., Ltd. obtained the "high-tech enterprise certificate" jointly issued by Shanghai Municipal Commission of Science and Technology, Shanghai Municipal Bureau of Finance and Shanghai Municipal Bureau of Taxation of the State Administration of Taxation.
More
2020-12-08
Good news - Luoqi Biology won two honors!
On November 2-3, the 2020 BPID Bio-pharmaceutical Industry Development Conference and the Star Show Awards Ceremony hosted by Medical Media was held in Suzhou.
More
2020-10-16
We will work together and forge ahead - the third anniversary of the founding of Loki Biology!
The cool autumn wind brought good news, and the rings of time left a glorious mark behind us. On October 16, 2020, Rocky Biological ushered in its third birthday! With the joint efforts of all colleagues, Luoqi Biology has successfully passed through three years. Here, thank everyone in Loki for their efforts! We are in the same boat. Thank you!
More
Total 51 123456